Literature DB >> 12692213

Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1.

Atsushi Koito1, Yuichi Kameyama, Cecilia Cheng-Mayer, Shuzo Matsushita.   

Abstract

In vivo studies for understanding viral transmission and replication, host immune responses, and pathogenesis of human immunodeficiency virus type 1 (HIV-1) infection would greatly benefit from the establishment of a small-animal model. In this study, we explored the potential of American mink (Mustera vison) as a susceptible host. We found that primary cells and cell lines derived from this species efficiently supported trans-activation of the HIV-1 long terminal repeat by Tat. Accordingly, the cysteine residue at position 261, which has been shown to be important for interaction of the human cyclin T1 with the HIV-1 regulatory protein Tat, is conserved in the mink homologue. No species-specific defect in Rev function could be detected in mink cells. In addition, primary splenocytes, fibroblasts, and the Mv.1.Lu cell line from American mink supported early as well as late HIV-1 gene expression following infection with vesicular stomatitis G protein-pseudotyped HIV-1 viruses, at levels comparable to those seen with permissive human cells. Furthermore, the mink Mv.1.Lu cell line stably expressing human CD4 and CCR5 receptors supported a spreading HIV-1 infection with few, if any, deficiencies compared to findings in human cell lines. This indicates the potential of HIV-1 to replicate in these cells once the blockade at the stage of virus entry has been removed. These results clearly show that cells from American mink generally pose no functional intracellular block to HIV-1 replication, and collectively they raise the possibility that this animal species could be engineered to support HIV-1 infection, providing a useful small-animal model for evaluating de novo infection by HIV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692213      PMCID: PMC153984          DOI: 10.1128/jvi.77.9.5109-5117.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

Authors:  M Baba; O Nishimura; N Kanzaki; M Okamoto; H Sawada; Y Iizawa; M Shiraishi; Y Aramaki; K Okonogi; Y Ogawa; K Meguro; M Fujino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 2.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

Authors:  E A Berger; P M Murphy; J M Farber
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  A block to human immunodeficiency virus type 1 assembly in murine cells.

Authors:  R Mariani; G Rutter; M E Harris; T J Hope; H G Kräusslich; N R Landau
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Human chromosome 6- and 11-encoded factors support human immunodeficiency virus type 1 Rev function in A9 cells.

Authors:  R R Shukla; S M Marques; P L Kimmel; A Kumar
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.

Authors:  J Lama; A Mangasarian; D Trono
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

6.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

Authors:  T M Ross; A E Oran; B R Cullen
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

7.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

Authors:  R I Connor; B K Chen; S Choe; N R Landau
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

9.  HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization.

Authors:  A S Baur; E T Sawai; P Dazin; W J Fantl; C Cheng-Mayer; B M Peterlin
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

10.  Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits.

Authors:  C S Dunn; M Mehtali; L M Houdebine; J P Gut; A Kirn; A M Aubertin
Journal:  J Gen Virol       Date:  1995-06       Impact factor: 3.891

View more
  8 in total

Review 1.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

2.  High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.

Authors:  Hanna-Mari Tervo; Oliver T Keppler
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

3.  Productive replication of Vif-chimeric HIV-1 in feline cells.

Authors:  Melissa A Stern; Chunling Hu; Dyana T Saenz; Hind J Fadel; Olivia Sims; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Productive replication and evolution of HIV-1 in ferret cells.

Authors:  Hind J Fadel; Dyana T Saenz; Rebekah Guevara; Veronika von Messling; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.

Authors:  Naomi Tsurutani; Jiro Yasuda; Naoki Yamamoto; Byung-Il Choi; Motohiko Kadoki; Yoichiro Iwakura
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.

Authors:  Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mohammed Mansour Abbas Eid; Mayuko Shimoda; Terumasa Ikeda; Atsushi Koito; Phuong Pham; Myron F Goodman; Nobuo Sakaguchi
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

7.  TRIM5α and Species Tropism of HIV/SIV.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-01-24       Impact factor: 5.640

8.  The antiretroviral potency of APOBEC1 deaminase from small animal species.

Authors:  Terumasa Ikeda; Takeo Ohsugi; Tetsuya Kimura; Shuzo Matsushita; Yosuke Maeda; Shinji Harada; Atsushi Koito
Journal:  Nucleic Acids Res       Date:  2008-10-29       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.